Intelligence / Healthtech / New Clinical Trials
ClinicalLIVEUpdated 18 Nov 2026
New Clinical Trials
Clinical trials companies registered in the last 30 days, worldwide, with the sponsor, phase and countries.
Sources: ClinicalTrials.gov · Rebuilt weekly · Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase.
Trials
777
in the 30 days to 2026-11-18
Added in 30 days
777
to 18 Nov 2026
Top country
United States
192 · 25% of the list
Phase covered
8
distinct values
Snapshot · 18 Nov 2026
Explore all 777 Growth
By month
777
Signals
What the register says this week, and why it matters if you sell into it.
- United States leads with 192 of 777, then China (171).
- 777 added in the 30 days to 18 Nov 2026.
- 174 of the listed studies are device, diagnostic or digital-health studies (no drug phase).
- A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.
PostedSponsorStudyPhaseStatus
6 Nov 2026Institut PasteurCharacterization of Adaptive Immune Responses to Oropouche Virus (OROV) InfectionNot Yet Recruiting6 Nov 2026Jiangsu HengRui Medicine Co., Ltd.ChinaEfficacy and Safety of Once-Weekly SHR-3167 Compared With Once-Daily Insulin Glargine in Adults With Insulin-Naive Type 2 DiabetesPhase 3Not Yet Recruiting6 Nov 2026Merck Sharp & Dohme LLCA Clinical Trial of MK-6916 in Participants With Moderate and Severe Kidney Disease Compared to Healthy Controls (MK-6916-013)Phase 1Not Yet Recruiting6 Nov 2026Meta Platforms Technologies LLCUnited StatesSpeech Recognition With Hearing EnhancementNot applicableCompleted6 Nov 2026Mirum Pharmaceuticals, Inc.United StatesExpanded-Access Program for the Treatment of Chronic Hepatitis D With BrelovitugAvailable6 Nov 2026Neurelis, Inc.Pharmacokinetics and Relative Bioavailability of Intranasal vs Intramuscular Olanzapine in Healthy Adult ParticipantsPhase 1Not Yet Recruiting6 Nov 2026Novartis PharmaceuticalsExtension Study of Safety and Tolerability of DDY391 in Participants With Moderate to Severe Psoriatic Arthritis (CDDY391A12201-extension)Phase 2Not Yet Recruiting6 Nov 2026Novartis PharmaceuticalsAn Ascending Dose Study of DKB903 in Participants With Rheumatoid Arthritis (RA) and Participants With Systemic Lupus Erythematosus (SLE)Phase 1Not Yet Recruiting6 Nov 2026Personalized Stem Cells, Inc.United StatesPilot Safety and Exploratory Efficacy of PSC-05 for the Treatment of Chronic Mild Traumatic Brain InjuryPhase 1Enrolling By Invitation6 Nov 2026Rapport Therapeutics Inc.AustraliaStudy Designed to Evaluate the Safety, Tolerability, and PK of RAP-219 Formulated as an Long Acting Injectable.Phase 1Recruiting6 Nov 2026SanofiAn Open-label, DDI Study to Investigate the Effects of Duvakitug on the PK of Selected Cytochrome P450 SubstratesPhase 1Not Yet Recruiting6 Nov 2026SanofiPhase 2 and 3 Placebo Controlled & Long-term Extension Study of Rilzabrutinib in Adults With iCVID to Evaluate Efficacy, Safety, and TolerabilityPhase 2, Phase 3Not Yet Recruiting6 Nov 2026Shenzhen Salubris Pharmaceuticals Co., Ltd.ChinaA Phase 2 Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of SAL0150 Tablets in Subjects With Type 2 Diabetes MellitusPhase 2Not Yet Recruiting6 Nov 2026Spinal Simplicity LLCCanadaCANLINK: Evaluation of the Intralink Intradiscal Device for Low Back Pain Due to Degenerative Disc DiseaseNot applicableNot Yet Recruiting6 Nov 2026Sun Pharma Advanced Research Company LimitedUnited StatesStudy of Electrocardiogram (ECG) Safety of Sezaby in Neonatal SeizuresPhase 4Not Yet Recruiting6 Nov 2026Syndax PharmaceuticalsA Study to Assess the Pharmacokinetics and Safety of Revumenib in Participants With Advanced Cancer and Hepatic or Renal ImpairmentPhase 1Not Yet Recruiting6 Nov 2026Techpool Bio-Pharma Co., Ltd.ChinaPharmacokinetics, Safety and Tolerability of Single Sequential and Multiple Intravenous Infusions of Ulinastatin for Injection in Healthy Chinese ParticipantsPhase 1Not Yet Recruiting6 Nov 2026The United Bio-Technology (Hengqin) Co., Ltd.ChinaA Study of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Food Effect of UBT48128 Tablets in Healthy ParticipantsPhase 1Not Yet Recruiting6 Nov 2026United TherapeuticsUnited StatesAn Open-Label Extension Study to Evaluate Inhaled Treprostinil SMI in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD)Phase 2, Phase 3Not Yet Recruiting6 Nov 2026United TherapeuticsUnited StatesStudy of Treprostinil Administered Via Soft Mist Inhaler (SMI) in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD)Phase 2Not Yet Recruiting6 Nov 2026Viatris Inc.United StatesA Phase 1/2 Clinical Trial to Evaluate the Safety and Efficacy of MR-146 in Subjects With Stage I and Stage II Neurotrophic KeratopathyPhase 1, Phase 2Recruiting6 Nov 2026Vivalyx GmbHHypothermic Kidney Machine Perfusion With OmnisolNot applicableNot Yet Recruiting6 Nov 2026Zi Diligence BiocenterEgyptAn Open-label, Randomized, Single Oral Dose, Two-period, Two-sequence, Two-way, Crossover Bioequivalence Study on Healthy Adult Male Participants Under Fed Conditions to Compare, Test Product Palbociclib-EVAPHARMA 125 mg Hard Gelatin Capsule, Versus the Reference Product Ibrance™125 mg CapsulesPhase 1Completed5 Nov 2026Amber Implants B.V.United StatesA Clinical Study to Collect Real-wordt Data on Safety and Clinical Performance of the VCFix Spinal System for Treatment of Vertebral Compression Fractures of (Suspected) Osteoporotic Origin.Recruiting5 Nov 2026Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.ChinaClinical Trial of Recombinant Herpes Zoster Vaccine (ZFA01 Adjuvant, CHO Cells)Phase 1, Phase 2Recruiting5 Nov 2026Avata Biosciences Holdings LtdA Clinical Study to Assess the Safety, Tolerability and Pharmacokinetics of Orally Administered Cannabidiol Capsules (AVAT-121) and Epidyolex® in Healthy AdultsPhase 1Not Yet Recruiting5 Nov 2026Beijing Supreme Life Pharmaceutical Technology Co., Ltd.ChinaFuling Yunhua Granules and Dihuang Baoyuan Granules in Adults With Type 2 Diabetes and Poor Glycemic Control Despite Lifestyle InterventionPhase 2Not Yet Recruiting5 Nov 2026Brainfarma Industria Química e Farmacêutica S/ABrazilCosmetic Efficacy Evaluation of Hydraporin AI Cream in Individuals With Atopic Dermatitis and PsoriasisNot applicableNot Yet Recruiting5 Nov 2026BrightGene Bio-Medical Technology Co., Ltd.ChinaA Study to Evaluate Efficacy and Safety of BGM1812 Injection in Overweight or Obese Participants Without DiabetesPhase 2Not Yet Recruiting5 Nov 2026Croma-Pharma GmbHPost-Approval Study of Saypha® ChIQ™ for Midface Augmentation in Subjects With Fitzpatrick Skin Types V and VINot applicableNot Yet Recruiting5 Nov 2026Cutis Medical Laser Clinics Pte LtdSingaporeEffectiveness of Sequential Monopolar and Bipolar Radiofrequency Device for Facial Rejuvenation in Female ParticipantsNot applicableCompleted5 Nov 2026DianosicSafety and Tolerability of Fluticasone Propionate 10% Nasal Insert in Participants With Chronic Allergic RhinitisPhase 1Not Yet Recruiting5 Nov 2026Eli Lilly and CompanyUnited StatesA Study of Imlunestrant (LY3484356) in Healthy Female ParticipantsPhase 1Not Yet Recruiting5 Nov 2026ESIItalyFood Supplement for Individuals With Polygenic HypercholesterolaemiaNot applicableRecruiting5 Nov 2026Gan & Lee Pharmaceuticals.ChinaComparison of Pharmacokinetic/Pharmacodynamic Characteristics and Safety of GZR101-80 Injection With Separately Injected, Simultaneous Doses of GZR33 Injection and Insulin AspartPhase 1Recruiting5 Nov 2026Hoffmann-La RocheA Clinical Study Testing Enicepatide in Participants Living With Overweight or Obesity and Cardiovascular DiseasePhase 3Not Yet Recruiting5 Nov 2026Innoventric LTDTRI-SUCCESS - Tricuspid Regurgitation Study of the Unica™ Cross-Caval System for the Evaluation of Efficacy and Safety in Significant TR SubjectsNot applicableNot Yet Recruiting5 Nov 2026IR INNOVATE RESEARCH PRIVATE LIMITEDVietnamSafety, Tolerability, and Clinical Effectiveness of Adapalene/Clindamycin Phosphate Gel (Klenzit®-C) in Vietnamese Patients With Mild to Moderate Acne VulgarisPhase 4Recruiting5 Nov 2026Jiangsu Chuangyuan Life Science and Technology Co., Ltd.ChinaCPU-YL01 Injection in Patients With Chronic Hepatitis B.Phase 1Enrolling By Invitation5 Nov 2026Kyorin Pharmaceutical Co.,LtdCanadaA Study to Evaluate the Effects of Therapeutic and Supratherapeutic Doses of KRP-S124 Compared to Placebo With Moxifloxacin on QTc Interval in Healthy ParticipantsPhase 1Recruiting5 Nov 2026machineMD AGAssessment of Binocular Vision Function With Neos™ (ROCKET)Not applicableNot Yet Recruiting5 Nov 2026Merck Sharp & Dohme LLCA Clinical Trial of MK-7602 in Healthy Volunteers (MK-7602-006)Phase 1Not Yet Recruiting5 Nov 2026Merck Sharp & Dohme LLCA Clinical Trial of MK-1045 With Zilovertamab Vedotin in Participants With Diffuse Large B-cell Lymphoma (MK-1045-010)Phase 2, Phase 3Not Yet Recruiting5 Nov 2026ModernaTX, Inc.UgandaA Study to Investigate the Safety and Immunogenicity of mRNA-1469 in African Participants 1 to 65 Years of AgePhase 1Not Yet Recruiting5 Nov 2026ModernaTX, Inc.United KingdomA Study to Investigate the Safety, Reactogenicity, and Immunogenicity of a Preventative Vaccine for Marburg Virus (mRNA-1519) in Healthy Adult ParticipantsPhase 1Not Yet Recruiting5 Nov 2026Novartis PharmaceuticalsRemibrutinib in Real-world Clinical Practice - a South Korea Sub-StudyNot Yet Recruiting5 Nov 2026Novo Nordisk A/SUnited States, Argentina, AustraliaA Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and ObesityPhase 3Not Yet Recruiting5 Nov 2026PfizerUnited States, CanadaA Study to Learn About Study Medicine Called Berobenatide in Adults With Knee Pain and Overweight or Obesity (VESPER-OA 1)Phase 3Recruiting5 Nov 2026Restore Biologics Holdings, Inc. dba XtresséUnited StatesStudy to Evaluate Xtressé Gummy Supplement in Women With Thinning HairNot applicableNot Yet Recruiting5 Nov 2026SanofiPharmacokinetics, Immunogenicity and Safety of Subcutaneous Dupilumab and Berahyaluronidase Alfa (ALT-B4) CoformulationPhase 3Not Yet Recruiting// How AOS uses this